Results
eNauka >
Rezultati >
A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase
| Naziv: | A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase | Autori: | Pastores, Gregory; Petakov, Milan  ; Giraldo, P.; Rosenbaum, H.; Szer, J.; Deegan, PB; Amato, DJ; Mengel, E.; Tan, ES; Chertkoff, R.; |
Godina: | 2014 | Publikacija: | Blood cells, molecules & diseases | ISSN: | 1079-9796 Blood Cells Molecules and Diseases Pretraži identifikator |
Izdavač: | Orlando, FL : Academic Press | Tip rezultata: | Naučni članak | Kolacija: | vol. 53 br. 4 str. 253-260 | DOI: | 10.1016/j.bcmd.2014.05.004 | WoS-ID: | 000343527800016 | Scopus-ID: | 2-s2.0-84908116847 | PMID: | 24950666 | URI: | https://enauka.gov.rs/handle/123456789/200528 | URL: | https://www.sciencedirect.com/science/article/pii/S1079979614000552?via%3Dihub | Izvor metapodataka: | Migrirano iz RIS podataka | M-kategorija: | 22M22 - Međunarodni časopis kategorije M22 |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.